Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria
• Treatments: Interferon-alpha; Peginterferon alfa-2a; Ribavirin

Criteria

Inclusion Criteria:

• Patients 18 years of age.

• Patients with expected prison stay beyond the duration of follow-up period of the study.

• Patients with chronic HCV infection and detectable viral load to initiate treatment with standard therapy.

• Patients their written informed consent to participate in the study.

Exclusion Criteria:

• Patients previously treated with Interferon (IFN) and Ribavirin (RBV).

• Patients can not read or understand a written questionnaire at the discretion of the investigator.